Telix Pharmaceuticals (Telix Pharmaceuticals) Short-Term Capital Lease Obligation : $0.4 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Short-Term Capital Lease Obligation?

Telix Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.4 Mil.

Telix Pharmaceuticals's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 ($0.4 Mil) to Jun. 2023 ($0.0 Mil) but then increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($0.4 Mil).

Telix Pharmaceuticals's annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($0.4 Mil) to Dec. 2022 ($0.4 Mil) and declined from Dec. 2022 ($0.4 Mil) to Dec. 2023 ($0.4 Mil).

Telix Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Telix Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Short-Term Capital Lease Obligation Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.01

0.38

0.44

0.43

0.40

Telix Pharmaceuticals Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial								0.44	-	0.43	-	0.40

Telix Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Telix Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

TLX:Australia

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.